0001209191-22-005447.txt : 20220128
0001209191-22-005447.hdr.sgml : 20220128
20220128170313
ACCESSION NUMBER: 0001209191-22-005447
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220126
FILED AS OF DATE: 20220128
DATE AS OF CHANGE: 20220128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoekman John
CENTRAL INDEX KEY: 0001855676
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40353
FILM NUMBER: 22569823
MAIL ADDRESS:
STREET 1: C/O IMPEL NEUROPHARMA, INC.
STREET 2: 201 ELLIOTT AVE. W, ST. 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPEL NEUROPHARMA INC
CENTRAL INDEX KEY: 0001445499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263058238
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
BUSINESS PHONE: 206-568-1466
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-26
0
0001445499
IMPEL NEUROPHARMA INC
IMPL
0001855676
Hoekman John
C/O IMPEL NEUROPHARMA, INC.
201 ELLIOTT AVE. W, ST. 260
SEATTLE
WA
98119
0
1
0
0
Chief Scientific Officer
Stock Option (right to buy)
9.85
2022-01-26
4
A
0
35000
0.00
A
2032-01-25
Common Stock
35000
35000
D
The option vests as to 2.0833% of the total shares on February 26, 2022 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on January 26, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ John Leaman, M.D. as attorney-in-fact
2022-01-28